XTRA:PCZ
XTRA:PCZBanks

Why ProCredit Holding (XTRA:PCZ) Cut Its 2025 ROE Guidance and What This Means for Its Risk Appetite

In October 2025, ProCredit Holding AG’s Management Board revised the group’s 2025 return on equity guidance down to 7-8% from about 10%, citing increased loss allowances for the upcoming year. This development highlights the firm’s more cautious view on loan performance, even as guidance for loan portfolio growth and capital strength remains steady. We'll now explore how this lowered profit expectation, and its link to higher projected loss allowances, may shift ProCredit Holding's...
XTRA:ADS
XTRA:ADSLuxury

Adidas (XTRA:ADS) Net Margin Surges to 4.9%, Underscoring Profit Growth Narrative After 217% Earnings Jump

Adidas (XTRA:ADS) posted a net profit margin of 4.9%, up from 1.7% last year, and delivered 217% earnings growth over the past year. The company’s outlook points to revenue growing 7.6% per year and earnings set to rise 21.9% annually, both outpacing the broader German market. With margin gains, robust historic earnings improvement, and forecasts signaling continued profit acceleration, shareholders are likely to keep a close eye on the upbeat numbers and valuation debate. See our full...
XTRA:HEN3
XTRA:HEN3Household Products

Assessing Henkel (XTRA:HEN3) Valuation After New Shanghai Packaging RecycLab Boosts Sustainability Ambitions

Henkel KGaA (XTRA:HEN3) just announced the launch of its new Packaging RecycLab in Shanghai, focusing on recycling innovation and advanced adhesive technologies. This investment reflects Henkel’s focus on sustainability and its efforts to strengthen its footprint in China. See our latest analysis for Henkel KGaA. Henkel KGaA’s launch of the Shanghai Packaging RecycLab comes as the stock shows some renewed momentum, with a 5.5% gain in the last 90 days. However, the year-to-date share price...
XTRA:AOF
XTRA:AOFSoftware

Is Upgraded 2025 Guidance and New CRO Shifting the Investment Case for ATOSS Software (XTRA:AOF)?

ATOSS Software SE raised its full-year 2025 guidance, lifting its EBIT margin forecast to 34% and targeting total revenues of around €190 million, following strong third-quarter results with year-on-year growth in revenue and net income. Alongside these financial updates, the company announced that Joachim Schreiner, a seasoned executive with international experience, will join as Chief Revenue Officer to support expansion and drive future growth. With enhanced guidance reflecting improved...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank (XTRA:DBK) Is Up 8.2% After Record Q3 Earnings and Investment Banking Surge Has The Bull Case Changed?

Deutsche Bank recently reported record third-quarter earnings, with net income rising to €1.56 billion as investment banking revenue saw significant growth, notably in fixed income trading. This strong financial performance, which exceeded expectations, comes just weeks ahead of the bank's upcoming strategy update and reflects momentum under CEO Christian Sewing. Next, we'll examine how this record-setting quarter and stronger investment bank performance impact Deutsche Bank's investment...
XTRA:HAG
XTRA:HAGAerospace & Defense

Why Hensoldt (XTRA:HAG) Is Down 5.0% After Cutting Its 2025 Revenue Guidance

Hensoldt AG recently lowered its earnings guidance for 2025, now expecting revenue to total approximately €2.50 billion versus the prior outlook of €2.50 billion to €2.60 billion. This downward revision in revenue expectations signals management's more cautious outlook amid changing market conditions and could shift investor sentiment. We will explore how Hensoldt's revised outlook may challenge the earlier investment narrative, particularly around confidence in future revenue growth. We've...
XTRA:RDC
XTRA:RDCConsumer Retailing

Redcare Pharmacy (XTRA:RDC): Valuation Perspectives After Nine-Month Sales Growth and Narrowed Net Loss

Redcare Pharmacy (XTRA:RDC) just released its earnings for the first nine months of 2025, showing sales growth to €2,145.71 million and a narrowed net loss of €8.71 million compared to last year. See our latest analysis for Redcare Pharmacy. Redcare Pharmacy’s latest earnings update arrives as the share price continues to face headwinds, sliding nearly 46% year-to-date. While the recent results point to real progress on revenue growth and loss reduction, the market remains cautious. With a...
XTRA:BAS
XTRA:BASChemicals

BASF (XTRA:BAS) Turns Profitable, but One-Off Loss Raises Doubts on Earnings Quality

BASF (XTRA:BAS) has returned to profitability, with net profit margins improving compared to last year. Over the past five years, however, the company’s earnings have declined by an average of 16.6% per year. Looking ahead, BASF’s earnings are forecast to grow at 19.4% annually, exceeding the German market’s average of 16.7%. However, anticipated revenue growth of 2.4% lags behind the expected 6.1% rate for the broader German market. Investors face a mixed picture as they weigh signs of...
XTRA:EOAN
XTRA:EOANIntegrated Utilities

How Investors Are Reacting To E.ON (XTRA:EOAN) Teaming With Nokia on Greener Grid Technology

Nokia recently announced a multi-year partnership with E.ON SE to upgrade the utility's mission-critical telecommunications network infrastructure across Germany, targeting improved automation, flexibility, and energy savings. The project positions E.ON’s grid, which already connects 1.4 million renewable energy plants, as a benchmark for secure, energy-efficient digital infrastructure supporting Europe’s energy transition. We’ll explore how E.ON’s collaboration with Nokia to cut network...
XTRA:VOS
XTRA:VOSMachinery

Does Vossloh (XTRA:VOS) Face a Strategic Test Amid Deutsche Bahn Project Delays?

Earlier this week, Kepler Cheuvreux downgraded Vossloh AG from Buy to Hold, citing valuation concerns following a strong rally and highlighting potential delays in infrastructure projects by Deutsche Bahn, Vossloh’s key customer. This move has drawn attention to how reliant Vossloh is on timely execution of its main customer’s investment plans, elevating focus on the near-term business outlook. We’ll explore how the analyst’s concerns about delays in Deutsche Bahn’s infrastructure projects...
XTRA:ZAL
XTRA:ZALSpecialty Retail

A Look at Zalando (XTRA:ZAL) Valuation Following Anna Dimitrova’s Appointment as CFO

Zalando (XTRA:ZAL) just named Anna Dimitrova as its new Chief Financial Officer. The company is bringing in a seasoned finance leader as it sharpens its focus on growth and its evolving e-commerce strategy. See our latest analysis for Zalando. Zalando’s shares have faced a challenging run in 2024, with a 1-year total shareholder return of -10.8% and a 5-year total return of -71.9%. This reflects ongoing pressure across the sector despite recent leadership changes. While the latest executive...
XTRA:HFG
XTRA:HFGConsumer Retailing

HelloFresh (XTRA:HFG): Losses Deepen but 88% Forecast Earnings Growth Sets Up Profitable Turnaround Narrative

HelloFresh (XTRA:HFG) extended its loss-making streak this year, with net losses compounding at an alarming 70.3% annual rate over the past five years and no reported improvement in profitability. Despite these persistent losses and a modest 1.8% revenue growth forecast—well behind the German market’s 6% pace—the company is expected to turn profitable within three years. Forecasted earnings growth is 87.98% per year, a rate well above average. Shares are trading at €7.12, a sharp discount to...
XTRA:1COV
XTRA:1COVChemicals

Covestro (XTRA:1COV) Forecasted to Return to Profitability with 98% Annual Earnings Growth Expected

Covestro (XTRA:1COV) remains in the red, with losses deepening at an annualized rate of 53% over the past five years. Despite that backdrop, the company’s outlook remains compelling for investors: revenue is expected to grow 3.5% per year, while earnings are forecast to bounce back at a rapid 98.16% per year. This positions Covestro on track for profitability within three years. Shares are currently trading at €59.84, below an estimated fair value of €68.78 and lower than peer and sector...
XTRA:LHA
XTRA:LHAAirlines

Lufthansa (XTRA:LHA) Margin Expansion Reinforces Value Narrative Despite Slower Projected Growth

Deutsche Lufthansa (XTRA:LHA) posted an annual earnings growth rate of 68.1% over the past five years, with its net profit margin rising to 4.6% from 3.3% a year earlier. While forward-looking forecasts call for earnings to climb by 3.85% per year and revenue to rise 3.7% annually, both metrics lag behind broader German market expectations. Still, the combination of improved profitability and a Price-to-Earnings ratio of 5.1x, well below industry peers and the global airline average, makes...
XTRA:SY1
XTRA:SY1Chemicals

Symrise (XTRA:SY1): Exploring Valuation After Q3 2025 Sales Growth and Outlook Update

Symrise (XTRA:SY1) shared its third quarter 2025 sales results, reporting organic growth of 1.4% despite tough year-on-year comparisons and the impacts of portfolio changes and currency fluctuations. Investors are watching how sustained project activity influences outlook. See our latest analysis for Symrise. Symrise shares are down 28.3% year-to-date, while the total shareholder return over the past year has dipped 32.8%. The latest positive sales update and a strong project pipeline have...
XTRA:MRK
XTRA:MRKPharmaceuticals

How Investors Are Reacting To Merck KGaA (XTRA:MRK) Partnering With Promega For 3D Drug Discovery Technologies

MilliporeSigma, the North American Life Science business of Merck KGaA, recently announced a partnership with Promega Corporation to co-develop advanced technologies for drug screening and discovery, integrating expertise in organoids, synthetic chemistry, and cellular assays. This collaboration aims to provide innovative workflows for real-time tracking of cellular activity and studying protein interactions in 3D cell cultures, reinforcing Merck KGaA's role in life sciences...
XTRA:DWS
XTRA:DWSCapital Markets

DWS Group (XTRA:DWS) Margin Jump Challenges Cautious Forecasts Despite Revenue Decline Outlook

DWS Group GmbH KGaA (XTRA:DWS) just posted annual earnings growth of 35.3%, a sharp jump over its five-year trend of only 1% annual growth. Although net profit margins have climbed from 15.1% to 18.5%, revenue is forecast to decline by 5.9% per year over the next three years, and earnings growth of 6.9% per year is projected to trail the broader German market’s 16.6% average. With the company trading at €55.4 per share, well below a fair value estimate of €94.44, and no major risks on the...
XTRA:PUM
XTRA:PUMLuxury

PUMA (XTRA:PUM): Is the Sportswear Giant Undervalued After a Challenging Year?

PUMA (XTRA:PUM) shares have seen some ups and downs in recent months, sparking fresh debate about the company’s outlook. Investors are taking a closer look at value, particularly after a tough year for returns. See our latest analysis for PUMA. After a tough slide since the start of the year, PUMA’s 1-year total shareholder return sits at -53.84%. This makes the recent 8.8% drop in its share price feel less like a blip and more a signal that momentum remains under pressure. Longer-term...